Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Exercise/Conversion of 87,373 ELVN shares, $216.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 87,373 | $216.7K |
| Feb 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 17,126 | n/a |
| Feb 10, 2025 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 20,491 | n/a |
| Feb 16, 2024 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 16,835 | n/a |
| Apr 7, 2023 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 27,567 | n/a |
| Feb 28, 2023 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 87,373 | n/a |